Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
N
Shared by NobleBlocks on Jun 20, 2017 • 12:00 AM UTC
Authors:
Alan P. Venook
,
Donna Niedzwiecki
,
Heinz-Josef Lenz
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With
<i>KRAS</i>
Wild-Type Advanced or Metastatic Colorectal Cancer | NobleBlocks
